Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;193(1):5-6.
doi: 10.1002/ajmg.c.32039.

Note from the editors

Affiliations

Note from the editors

Tiina K Urv et al. Am J Med Genet C Semin Med Genet. 2023 Mar.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Brooks, P. J., Urv, T. K., & Parisi, M. A. (2023). Gene-targeted therapies: Overview and implications. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 193(1), 13-18. https://doi.org/10.1002/ajmg.c.32033
    1. Garrison, L. P., Lo, A. W., Finkel, R. S., & Deverka, P. A. (2023). A review of economic issues for gene-targeted therapies: Value, affordability, and access. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 193(1), 64-76. https://doi.org/10.1002/ajmg.c.32037
    1. Gaviglio, A. M., Skinner, M. W., Lou, L. J., Finkel, R. S., Augustine, E. F., & Goldenberg, A. J. (2023). Gene-targeted therapies: Towards equitable development, diagnosis, and access. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 193(1), 56-63. https://doi.org/10.1002/ajmg.c.32032
    1. Lekstrom-Himes, J., Augustine, E. F., Brower, A., Defay, T., Finkel, R. S., McGuire, A. L., … Yu, T. W. (2023). Data sharing to advance gene-targeted therapies in rare diseases. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 193(1), 87-98. https://doi.org/10.1002/ajmg.c.32028
    1. Lekstrom-Himes, J., Brooks, P. J., Koeberl, D. D., Brower, A., Goldenberg, A., Green, R. C., … Augustine, E. F. (2023). Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 193(1), 30-43. https://doi.org/10.1002/ajmg.c.32031

LinkOut - more resources